Who’s under contract for next season, who’s a pending free agent, salary cap issues and tough personnel decisions after ...

After building around the margins last offseason, the Chargers are positioned to make a splash in Jim Harbaugh's second ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

According to an online rumor that emerged in mid-January 2025, actor Denzel Washington donated $50 million to help victims of wildfires that caused significant property destruction in the Los ...

At the top of the list of snubs this year are “Wicked,” which missed out on the best film category, and Denzel Washington (“Gladiator II”) who, despite being one of the most celebrated ...

As Shakespeare wrote, “Life is but a walking shadow,” and Denzel Washington is the poor player who continues to be heard no more, at least in the eyes of BAFTA. With over 65 film credits ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Both previous Paddington movies received multiple BAFTA noms. In one of the more bizarre awards season streaks, Denzel Washington remains without a single BAFTA nomination across his illustrious ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

Absent from the supporting actor category is Denzel Washington for his role in Gladiator II, Ridley Scott's sequel to the 2000 epic. For the best film prize, the nomination frontrunner Conclave ...

Employees are advised to complete this process promptly to access benefits under the Employment Linked Incentive (ELI) scheme. Why UAN activation is important? UAN, a unique 12-digit identifier ...

Eli Lilly and Co. LLY Eli Lilly’s shares fell 6.59%, closing at $744.91. The stock had an intraday high of $784.23 and a low of $729, with a 52-week range of $612.7 to $972.53. The company ...